Spero Therapeutics

SPRO65

High Value

$1.15arrow_drop_down0.84%-$0.01

High Value

Penny Stock

SPRO65

$1.15

arrow_drop_down0.84%-$0.01

High Value

Penny Stock

Performance History

Key Stats
Open	$1.25
Prev. Close	$1.25
EPS	0.34
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$63.77M

	LOW	HIGH
Day Range	1.17	1.28
52 Week Range	0.85	1.89

Ratios

Revenue	-





EPS	0.34

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Spero Therapeutics (SPRO)

Spero Therapeutics Inc (SPRO) is a biopharmaceutical company focused on developing novel treatments for serious bacterial infections. The company’s mission is to transform the way bacterial infections are treated by targeting drug-resistant bacteria. SPRO is committed to addressing the urgent and growing need for new antibiotics that can combat the rise of antibiotic resistance, a global health crisis.

With a market cap of xxx million, Spero Therapeutics Inc is actively involved in the research, development, and commercialization of innovative therapies. The company’s innovative approach focuses on developing treatments that target the underlying mechanisms of bacterial resistance, enabling the development of potent and effective therapies.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Satyavrat Shukla C.F.A.
Headquarters: Cambridge
Employees: 35
Exchange: NASDAQ

Keep an eye on Spero Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Spero Therapeutics 's (SPRO) price per share?

The current price per share for Spero Therapeutics (SPRO) is $1.16. The stock has seen a price change of -$0.01 recently, indicating a -0.85% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Spero Therapeutics (SPRO)?

For Spero Therapeutics (SPRO), the 52-week high is $1.89, which is 63.49% from the current price. The 52-week low is $0.85, the current price is 35.84% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Spero Therapeutics (SPRO) a growth stock?

Spero Therapeutics (SPRO) has shown an average price growth of -6.8% over the past three years. It has received a score of 8 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Spero Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Spero Therapeutics (SPRO) stock price performance year to date (YTD)?

As of the latest data, Spero Therapeutics (SPRO) has a year-to-date price change of -23.95%. Over the past month, the stock has experienced a price change of -10.04%. Over the last three months, the change has been -8.98%. Over the past six months, the figure is -27.3%. Looking at a longer horizon, the five-year price change stands at -87.78%.

help

Is Spero Therapeutics (SPRO) a profitable company?

Spero Therapeutics (SPRO) has a net income of $22.81M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -186.93% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 99.13%, providing insight into the company's sales performance and growth. The gross profit is $96.37M. Operating income is noted at $21.48M. Furthermore, the EBITDA is $31.08M.

help

What is the market capitalization of Spero Therapeutics (SPRO)?

Spero Therapeutics (SPRO) has a market capitalization of $63.78M. The average daily trading volume is 1.2, indicating the stock's liquidity and investor engagement.